|
PIGA expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.617800E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.197040E-03 |
| Normal-vs-Stage2 |
1.490020E-02 |
| Normal-vs-Stage3 |
1.854350E-01 |
| Normal-vs-Stage4 |
5.142400E-01 |
| Stage1-vs-Stage2 |
6.141200E-01 |
| Stage1-vs-Stage3 |
7.766100E-02 |
| Stage1-vs-Stage4 |
9.402500E-03 |
| Stage2-vs-Stage3 |
1.187830E-01 |
| Stage2-vs-Stage4 |
4.526200E-02 |
| Stage3-vs-Stage4 |
4.844400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.317900E-03 |
| Normal-vs-AfricanAmerican |
1.243650E-01 |
| Normal-vs-Asian |
3.691600E-01 |
| Caucasian-vs-AfricanAmerican |
8.044200E-01 |
| Caucasian-vs-Asian |
9.697800E-01 |
| AfricanAmerican-vs-Asian |
9.559200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.829810E-02 |
| Normal-vs-Female |
5.038500E-03 |
| Male-vs-Female |
3.975600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.868800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.840200E-03 |
| Normal-vs-Age(61-80Yrs) |
1.350410E-02 |
| Normal-vs-Age(81-100Yrs) |
1.691770E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.890770E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.533400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.588400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.415600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.444400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.473000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.907830E-02 |
| Normal-vs-Grade 2 |
2.165900E-04 |
| Normal-vs-Grade 3 |
1.361150E-01 |
| Normal-vs-Grade 4 |
9.189800E-01 |
| Grade 1-vs-Grade 2 |
7.337000E-01 |
| Grade 1-vs-Grade 3 |
9.423800E-02 |
| Grade 1-vs-Grade 4 |
1.905780E-02 |
| Grade 2-vs-Grade 3 |
2.963900E-03 |
| Grade 2-vs-Grade 4 |
1.406450E-04 |
| Grade 3-vs-Grade 4 |
1.020020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.769330E-04 |
| Normal-vs-ccB subtype |
2.626500E-02 |
| ccA subtype-vs-ccB subtype |
1.664020E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.362360E-02 |
| Normal-vs-N1 |
5.371800E-01 |
| N0-vs-N1 |
1.530060E-02 |
|
|
